Northfield Laboratories, Inc.
Records under this name other than patents Northfield Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Northfield Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,202,341 | Stabilized hemoglobin solutions Formerly held Lapsed on the fee record Ended Apr 10, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2019 | From the USPTO record |
| US 6,133,425 | Acellular red blood cell substitute Formerly held Term ended Term ended Oct 17, 2017 · From the USPTO record | Term ended | Term ended Oct 17, 2017 | From the USPTO record |
| US 7,521,417 | Method and apparatus for preparing an acellular red blood cell substitute Formerly held Term ended Ended no later than Mar 27, 2017 · From the USPTO record | Term ended | Ended no later than Mar 27, 2017 | From the USPTO record |
| US 7,435,795 | Stabilized hemoglobin solutions Formerly held Lapsed on the fee record Ended Oct 14, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2016 | From the USPTO record |
| US 7,411,044 | Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing Formerly held Lapsed on the fee record Ended Aug 12, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2016 | From the USPTO record |
| US 7,291,592 | Method for treating patients with massive blood loss Formerly held Lapsed on the fee record Ended Nov 6, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2015 | From the USPTO record |
| US 6,498,141 | Method and apparatus for preparing an acellular red blood cell substitute Formerly held Lapsed on the fee record Ended Dec 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 24, 2014 | From the USPTO record |
| US 6,323,320 | Acellular red blood cell substitute Formerly held Lapsed on the fee record Ended Nov 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2013 | From the USPTO record |
| US 7,135,553 | Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing Formerly held Lapsed on the fee record Ended Nov 14, 2010 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2010 | From the USPTO record |
| US 6,914,127 | Acellular red blood cell substitute Formerly held Term ended Term ended Jul 2, 2007 · From the USPTO record | Term ended | Term ended Jul 2, 2007 | From the USPTO record |